Regulatory Affairs: The IND, NDA, and Post-Marketing

Attend this virtual training course to learn about FDA regulations and expectations for the content, submission and review of INDs/NDAs, and the importance of regulatory strategy.

Back to Agenda

Introduction to Regulation of Drugs and Biologics in the United States: Pre-Course Part Two

Session Chair(s)

Carol H. Danielson, DrPH, MS, RAC

President

Regulatory Advantage, LLC, United States

Introduction to Regulation of Drugs and Biologics in the United States: Pre-Course Part Two

Have an account?

Regulatory Affairs: The IND, NDA, and Post-Marketing

Introduction to Regulation of Drugs and Biologics in the United States: Pre-Course Part Two

Session Chair(s)

Carol H. Danielson, DrPH, MS, RAC

Be informed and stay engaged.